Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

BSLN.SW


Top 10 Correlated ETFs

BSLN.SW


Top 10 Correlated Stocks

BSLN.SW


Financial details

Company Rating
Sell
Market Cap
581.56M
Income
-24.65M
Revenue
133.92M
Book val./share
-7.44
Cash/share
16.54
Dividend
-
Dividend %
-
Employees
177
Optionable
No
Shortable
Yes
Earnings
13 Feb 2023
P/E
211.52
Forward P/E
-
PEG
35.48
P/S
3.91
P/B
-7.79
P/C
2.91
P/FCF
-7.68
Quick Ratio
0.91
Current Ratio
1.36
Debt / Equity
-2.47
LT Debt / Equity
-1.67
-
-
EPS (TTM)
-2.28
EPS next Y
-
EPS next Q
1.44
EPS this Y
-53.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.98%
Revenue last 5Y
7.85%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
8.87%
SMA50
22.19%
SMA100
23.77%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
32%
ROC
-0.22%
Gross Margin
86%
Oper. Margin
-13%
Profit Margin
-18%
Payout
-
Shs Outstand
11.84M
Shs Float
11.47M
-
-
-
-
Target Price
-
52W Range
29.55-49.85
52W High
-1.63%
52W Low
+66.21%
RSI
58.99
Rel Volume
0.6
Avg Volume
38.74K
Volume
23.35K
Perf Week
-0.21%
Perf Month
13.95%
Perf Quarter
45.18%
Perf Half Y
41.76%
-
-
-
-
Beta
0.879097
-
-
Volatility
0.71%, 2.01%
Prev Close
-1.83%
Price
48.2
Change
-3.02%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
9.3612.2312.4912.4114.41
Net income per share
-1.79-2.89-2.08-1.43-0.66
Operating cash flow per share
1.75-7.31-5.94-5.27-3.11
Free cash flow per share
1.67-7.36-5.97-5.49-3.2
Cash per share
23.8420.5811.9915.7314.46
Book value per share
-3.82-6.15-8.64-9.93-5.7
Tangible book value per share
-3.85-6.19-8.68-9.99-5.76
Share holders equity per share
-3.82-6.15-8.64-9.93-5.7
Interest debt per share
18.7118.7818.9824.3122.09
Market cap
832.96M566.28M607.7M524.36M447.24M
Enterprise value
830.59M590.26M696.44M705.97M612.5M
P/E ratio
-43.03-18.06-27.1-35.62-65.47
Price to sales ratio
8.24.274.524.113.02
POCF ratio
43.81-7.15-9.52-9.69-13.97
PFCF ratio
46.1-7.09-9.46-9.3-13.6
P/B Ratio
-20.1-8.49-6.54-5.14-7.63
PTB ratio
-20.1-8.49-6.54-5.14-7.63
EV to sales
8.184.455.185.534.14
Enterprise value over EBITDA
-80.17-25.94-48.64-119.9290.15
EV to operating cash flow
43.68-7.45-10.91-13.04-19.13
EV to free cash flow
45.97-7.4-10.84-12.52-18.63
Earnings yield
-0.02-0.06-0.04-0.03-0.02
Free cash flow yield
0.02-0.14-0.11-0.11-0.07
Debt to equity
-4.74-2.95-2.13-2.36-1.61
Debt to assets
1.121.241.421.441.24
Net debt to EBITDA
0.23-1.05-6.2-30.8578.28
Current ratio
3.694.122.454.461.38
Interest coverage
-2.12-3.53-2.44-2.820.37
Income quality
-0.982.532.853.684.69
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.520.24000
Research and developement to revenue
0.530.790.760.760.63
Intangibles to total assets
00000
Capex to operating cash flow
-0.050.010.010.040.03
Capex to revenue
-0.0100-0.02-0.01
Capex to depreciation
-0.47-0.33-0.25-1.9-1.14
Stock based compensation to revenue
0.050.050.020.030.03
Graham number
12.3920.0120.1317.889.23
ROIC
-0.05-0.11-0.11-0.120.04
Return on tangible assets
-0.06-0.11-0.1-0.06-0.03
Graham Net
-11.65-10.91-16.38-15.52-14.18
Working capital
213.49M208.05M109.37M173.37M66.66M
Tangible asset value
-41.77M-67.06M-93.33M-102.72M-59.24M
Net current asset value
-99.63M-73.7M-129.57M-108.31M-64.81M
Invested capital
-4.74-2.95-2.13-2.37-3.74
Average receivables
00000
Average payables
8.75M9.78M9.96M13.15M11.88M
Average inventory
18.26M17.8M19.88M21.19M21.99M
Days sales outstanding
00000
Days payables outstanding
176.05115.06130.87199.56160.98
Days of inventory on hand
619.59259.13359.22321.57345.46
Receivables turnover
00000
Payables turnover
2.073.172.791.832.27
Inventory turnover
0.591.411.021.141.06
ROE
0.470.470.240.140.12
Capex per share
-0.09-0.06-0.04-0.22-0.08

Quarterly Fundamentals Overview

Last date of statement is 2019-06-30 for Q2

Metric History 2015-06-302016-06-302017-06-302018-06-30 2019-06-30
Revenue per share
1.311.632.343.063.12
Net income per share
-1.52-1.27-0.45-0.72-0.52
Operating cash flow per share
-1.68-1.850.44-1.83-1.48
Free cash flow per share
-1.71-1.860.42-1.84-1.49
Cash per share
21.625.7818.7318.216.54
Book value per share
4.36-0.89-4.67-5.37-7.44
Tangible book value per share
4.34-0.91-4.69-5.39-7.47
Share holders equity per share
4.36-0.89-4.67-5.37-7.44
Interest debt per share
019.4318.2118.2918.5
Market cap
1.19B682.67M876.35M715.3M394.3M
Enterprise value
1.05B616.83M929.09M774.61M463.79M
P/E ratio
-19.27-13.31-45.27-22.82-17.59
Price to sales ratio
89.8941.3834.5321.5911.74
POCF ratio
-70.06-36.41184.36-36.12-24.71
PFCF ratio
-68.73-36.2194-35.85-24.55
P/B Ratio
26.95-76.1-17.3-12.29-4.93
PTB ratio
26.95-76.1-17.3-12.29-4.93
EV to sales
79.5337.3936.6123.3713.81
Enterprise value over EBITDA
-71.4-58.44-358.72-136.17-129.56
EV to operating cash flow
-61.98-32.9195.45-39.12-29.06
EV to free cash flow
-60.8-32.71205.68-38.82-28.88
Earnings yield
-0.01-0.02-0.01-0.01-0.01
Free cash flow yield
-0.01-0.030.01-0.03-0.04
Debt to equity
0-21.75-3.87-3.38-2.47
Debt to assets
0.821.031.171.191.34
Net debt to EBITDA
9.316.24-20.36-10.43-19.41
Current ratio
3.644.422.983.972.81
Interest coverage
-399.25-6.84-2.12-3.53-2.44
Income quality
1.11.46-0.982.532.85
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
1.140.730.530.790.76
Intangibles to total assets
00000
Capex to operating cash flow
0.020.01-0.050.010.01
Capex to revenue
-0.02-0.01-0.0100
Capex to depreciation
-0.52-0.19-0.47-0.33-0.25
Stock based compensation to revenue
0.180.120.050.050.02
Graham number
12.225.036.859.359.34
ROIC
-0.08-0.04-0.02-0.02-0.03
Return on tangible assets
-0.06-0.04-0.02-0.03-0.02
Graham Net
1.62-8.75-12.32-14.43-11.95
Working capital
170.07M218.99M156.27M185.12M146.91M
Tangible asset value
43.86M-9.24M-50.85M-58.47M-80.37M
Net current asset value
29.79M-71.62M-109.22M-115.85M-87.36M
Invested capital
0-21.75-3.87-3.38-2.47
Average receivables
00000
Average payables
5.96M5.91M6.55M6.11M6.96M
Average inventory
14.13M16.54M19.19M21.03M20.62M
Days sales outstanding
00000
Days payables outstanding
081.2698.7328.3663.15
Days of inventory on hand
0692.67622.27341.86352.18
Receivables turnover
00000
Payables turnover
01.110.913.171.43
Inventory turnover
00.130.140.260.26
ROE
-0.351.430.10.130.07
Capex per share
-0.03-0.01-0.02-0.01-0.01

Frequently Asked Questions

What is Basilea Pharmaceutica AG stock symbol ?

Basilea Pharmaceutica AG is a CH stock , located in Basel of Basel-stadt and trading under the symbol BSLN.SW

What is Basilea Pharmaceutica AG stock quote today ?

Basilea Pharmaceutica AG stock price is $48.2 today.

Is Basilea Pharmaceutica AG stock public?

Yes, Basilea Pharmaceutica AG is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap